報價延遲最少15分鐘:2026/11/14 14:46 EST
常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
4.94 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-0.02/--
|
|
企業價值
2.54B
|
| 資產負債 |
|
每股賬面淨值
0.03
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
0
|
|
每股收益
--
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比較之報價最少15分鐘延遲 (夜盤時段除外)
|
業務概覽
|
|||
| Regencell Bioscience Holdings Ltd is an early-stage bioscience company that focuses on research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, specifically ADHD and ASD. Its goal is to save and improve the lives of patients, their families and caregivers and become a market leader for the natural and holistic treatment globally. The company operates and manages its business as a single segment - in the research and development of the company's product candidates. |
